131 related articles for article (PubMed ID: 21921440)
1. [Discovery of an antiparkinsonian drug: zonisamide].
Murata M
Rinsho Shinkeigaku; 2010 Nov; 50(11):780-2. PubMed ID: 21921440
[TBL] [Abstract][Full Text] [Related]
2. [The discovery of an antiparkinsonian drug, zonisamide].
Murata M
Rinsho Shinkeigaku; 2010 Feb; 50(2):67-73. PubMed ID: 20196486
[TBL] [Abstract][Full Text] [Related]
3. Novel therapeutic effects of the anti-convulsant, zonisamide, on Parkinson's disease.
Murata M
Curr Pharm Des; 2004; 10(6):687-93. PubMed ID: 14965331
[TBL] [Abstract][Full Text] [Related]
4. Zonisamide: a new drug for Parkinson's disease.
Murata M
Drugs Today (Barc); 2010 Apr; 46(4):251-8. PubMed ID: 20502722
[TBL] [Abstract][Full Text] [Related]
5. Zonisamide has beneficial effects on Parkinson's disease patients.
Murata M; Horiuchi E; Kanazawa I
Neurosci Res; 2001 Dec; 41(4):397-9. PubMed ID: 11755227
[TBL] [Abstract][Full Text] [Related]
6. Zonisamide attenuates MPTP neurotoxicity in marmosets.
Choudhury ME; Moritoyo T; Yabe H; Nishikawa N; Nagai M; Kubo M; Matsuda S; Nomoto M
J Pharmacol Sci; 2010; 114(3):298-303. PubMed ID: 20948167
[TBL] [Abstract][Full Text] [Related]
7. Zonisamide inhibits monoamine oxidase and enhances motor performance and social activity.
Uemura MT; Asano T; Hikawa R; Yamakado H; Takahashi R
Neurosci Res; 2017 Nov; 124():25-32. PubMed ID: 28624436
[TBL] [Abstract][Full Text] [Related]
8. Zonisamide enhances delta receptor-associated neurotransmitter release in striato-pallidal pathway.
Yamamura S; Ohoyama K; Nagase H; Okada M
Neuropharmacology; 2009 Sep; 57(3):322-31. PubMed ID: 19482038
[TBL] [Abstract][Full Text] [Related]
9. The antiepileptic drug zonisamide inhibits MAO-B and attenuates MPTP toxicity in mice: clinical relevance.
Sonsalla PK; Wong LY; Winnik B; Buckley B
Exp Neurol; 2010 Feb; 221(2):329-34. PubMed ID: 19948168
[TBL] [Abstract][Full Text] [Related]
10. [Role of zonisamid in treating epilepsy, Parkinson disorders and other neurological diseases].
Janszky J
Ideggyogy Sz; 2009 Nov; 62(11-12):383-9. PubMed ID: 20025128
[TBL] [Abstract][Full Text] [Related]
11. Effects of zonisamide on dopaminergic system.
Okada M; Kaneko S; Hirano T; Mizuno K; Kondo T; Otani K; Fukushima Y
Epilepsy Res; 1995 Nov; 22(3):193-205. PubMed ID: 8991786
[TBL] [Abstract][Full Text] [Related]
12. [Therapy of Parkinson's disease--up to date].
Murata M
Rinsho Shinkeigaku; 2008 Nov; 48(11):986-8. PubMed ID: 19198140
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effects of zonisamide target astrocyte.
Asanuma M; Miyazaki I; Diaz-Corrales FJ; Kimoto N; Kikkawa Y; Takeshima M; Miyoshi K; Murata M
Ann Neurol; 2010 Feb; 67(2):239-49. PubMed ID: 20225289
[TBL] [Abstract][Full Text] [Related]
14. Zonisamide cotreatment delays striatal dopamine transporter reduction in Parkinson disease: A retrospective, observational cohort study.
Ikeda K; Yanagihashi M; Miura K; Ishikawa Y; Hirayama T; Takazawa T; Kano O; Kawabe K; Mizumura N; Iwasaki Y
J Neurol Sci; 2018 Aug; 391():5-9. PubMed ID: 30103971
[TBL] [Abstract][Full Text] [Related]
15. Novel dopamine releasing response of an anti-convulsant agent with possible anti-Parkinson's activity.
Gluck MR; Santana LA; Granson H; Yahr MD
J Neural Transm (Vienna); 2004 Jun; 111(6):713-24. PubMed ID: 15168218
[TBL] [Abstract][Full Text] [Related]
16. Effect of repeated treatment with high doses of selegiline on behaviour, striatal dopaminergic transmission and tyrosine hydroxylase mRNA levels.
Themann C; Alvarez Fischer D; Gross S; Westermann R; Weihe E; Kuschinsky K; Schäfer H; Ferger B
Naunyn Schmiedebergs Arch Pharmacol; 2002 Jan; 365(1):22-8. PubMed ID: 11862330
[TBL] [Abstract][Full Text] [Related]
17. Zonisamide for the treatment of Parkinson's disease.
Miwa H
Expert Rev Neurother; 2007 Sep; 7(9):1077-83. PubMed ID: 17868006
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacologic treatment of Parkinson disease].
Murata M
Brain Nerve; 2009 Apr; 61(4):464-72. PubMed ID: 19378816
[TBL] [Abstract][Full Text] [Related]
19. Effect of zonisamide co-administration with levodopa on global gene expression in the striata of rats with Parkinson's disease.
Ueda Y; Tokashiki S; Kanemaru A; Kojima T
Biochem Biophys Res Commun; 2012 Nov; 428(3):401-4. PubMed ID: 23103374
[TBL] [Abstract][Full Text] [Related]
20. Zonisamide increases dopamine turnover in the striatum of mice and common marmosets treated with MPTP.
Yabe H; Choudhury ME; Kubo M; Nishikawa N; Nagai M; Nomoto M
J Pharmacol Sci; 2009 May; 110(1):64-8. PubMed ID: 19403994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
